Back to Treatments

Treatment

Cetuximab (added to chemotherapy, RAS Wild-Type)

1
Conditions
150
Trials
20K
Participants
35%
Average Safety

Condition Evidence

Colon and rectum cancer

150 trials · 20K participants

75% effectiveness · 35% safety
Cetuximab (added to chemotherapy, RAS Wild-Type) | DFDA